HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database

Pediatric Diabetes

Volumn 14, Issue 8, 2013, Pages 562-574

  Awa, Wendy L ^a   Boehm, Bernard O ^b   Rosinger, Silke ^b   Achenbach, Peter ^c   Ziegler, Anette G ^c   Krause, Stephanie ^c   Meissner, Thomas ^e   Wiegand, Susanne ^d   Reinehr, Thomas ^f   Kapellen, Thomas ^g   Karges, Beate ^h   Eiermann, Thomas ⁱ   Schober, Edith ^j   Holl, Reinhard W ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e University Medical Center   (Germany)

^f UNIVERSITY OF WITTEN HERDECKE   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

cell autoimmunity; HLA DR genotype; Obesity; Therapy; Type 2 diabetes

Indexed keywords

DNA; HEMOGLOBIN A1C; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA DRB5 ANTIGEN; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ARTICLE; AUSTRIA; AUTOIMMUNITY; BODY MASS; CHILD; CHILDHOOD OBESITY; CLINICAL FEATURE; DATA BASE; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; FAMILY HISTORY; FEMALE; GENETIC RISK; GERMANY; HLA TYPING; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; MIGRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

HLA-DR-GENOTYPE; OBESITY; THERAPY; TYPE 2 DIABETES; Β-CELL AUTOIMMUNITY;

ADOLESCENT; AGE OF ONSET; AUSTRIA; AUTOANTIBODIES; CHILD; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; PHENOTYPE;

EID: 84888384364     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12043     Document Type: Article

References (35)

1. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693-700.
2. Dabelea D, DeGroat J, Sorrelman C et al; for the SEARCH for Diabetes in Youth Study Group. Diabetes in Navajo youth: prevalence, incidence and clinical characteristics. The SEARCH for Diabetes in Youth Study. Diabetes Care 2009: 32: 141-147.
3. The Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. J Am Med Assoc 2007: 297: 2716-2724.
4. Copeland KC, Zeitler P, Geffner M et al; for the TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011: 96: 159-167.
5. Neu A, Feldhahn L, Ehehalt S, Hub R, Ranke MB, DIARY group Baden-Württemberg. Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population-based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0-20years. Pediatr Diabetes 2009: 10: 468-473.
6. Schober E, Waldhoer T, Rami B, Hofer S, Austrian Diabetes Incidence Study Group. Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999-2007. J Pediatr 2009: 155: 190-193.
7. Rosenbauer J, Stahl A. Häufigkeit des Diabetes mellitus im Kindes- und Jugendalter in Deutschland. Diabetologe 2010: 6: 177-189.
8. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes in children and adolescents. Pediatr Diabetes 2009: 12: 17-32.
9. Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J Clin Endocrinol Metab 2006: 91: 401-404.
10. Gillies CL, Abrams KR, Lambert PC et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 2007: 334: 299-302.
11. Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care 2011: 34: 166-170.
12. Klingensmith GJ, Pyle L, Arslanian S et al; TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010: 33: 1970-1975.
13. Reinehr T, Schober E, Wiegand S, Thon A, Holl R, on behalf of the DPV-Wiss Study Group. β-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child 2006; 91: 473-477.
14. Rosenbauer J, Dost A, Karges B et al; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012: 35: 80-86.
15. Reinehr T, Wabitsch M, Andler W et al; APV Study Group. Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur J Pediatri 2004: 163: 308-312.
16. Kerner W, Brückel J. Definition, Klassifikation und Diagnostik des Diabetes mellitus. DDG Praxis-Leitlinie. Diabetologie 2011: 6: 107-110.
17. Position Statement American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011: 34: 11-61.
18. Bonifacio E, Yu L, Williams AK et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab 2010: 95: 3360-3367.
19. Achenbach P, Lampasona V, Landherr U et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009: 52: 1881-1888.
20. Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008: 51: 846-852.
21. Lampasona V, Schlosser M, Mueller PW et al. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem 2011: 57: 1693-1702.
22. Awa WL, Boehm B, Kapellen T et al. HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus. Eur J Endocrinol 2010: 163: 97-104.
23. AGA-Guidelines. Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter. www.a-g-a 2011: 123: 750-757.
24. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body-Mass-Index für das Kindes und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift für Kinderheilkunde 2001: 149: 807-818.
25. Awa WL, Fach E, Krakow D et al; on behalf of the DPV Initiative and the German BMBF Competence Networks Diabetes mellitus and Obesity. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120183 patients from the German/Austrian DPV database. Eur J Endocrinol 2012: 167: 245-254.
26. Röbl M, Knerr I, Keller KM et al. Obesity in children and adolescents and their parents. Correlation of standardized body mass index between patients, their parents and siblings from the multicentre APS data. Deutsche Medizinische Wochenschrift 2008: 133: 2448-2453.
27. Kinder- und Jugendgesundheitssurvey (KiGGS) 2003-2006: Kinder und Jugendliche mit Migrationshintergrund in Deutschland (RKI). 2008 http://www.kiggs.de/experten/downloads/dokumente/KiGGS_migration%5B1%5D.pdf (Accessed 19.06.12).
28. Uitewaal PJ, Manna DR, Bruijnzeels MA, Hoes AW, Thomas S. Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. Prev Med 2004: 39: 1068-1076.
29. Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IM, Kumar BN, Birkeland KI. Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women. BMC Public Health. 2012: 12: 150.
30. Thomas C, Nightingale CM, Donin AS et al. Socio-economic position and type 2 diabetes risk factors: patterns in UK children of South Asian, black African-Caribbean and white European origin. PLoS One 2012: 7: e32619.
31. Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 2012: 35: 1265-1271.
32. Farah SE, Wals KT, Friedman IB, Pisacano MA, DiMartino-Nardi J. Prevalence of retinopathy and microalbuminuria in pediatric type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2006: 19: 937-942.
33. Groop L, Tuomi T, Rowley M, Zimmet P, Mackay IR. Latent autoimmune diabetes in adults (LADA)-more than a name. Diabetologia 2006: 49: 1996-1998.
34. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999: 48: 150-157.
35. TODAY Study Group, Zeitler P, Hirst K et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. New Engl J Med 2012: 366: 2247-2256.